DK1200590T3 - C-type lectin-transmembran-antigen, der udtrykkes ved human prostatacancer, og anvendelser deraf - Google Patents

C-type lectin-transmembran-antigen, der udtrykkes ved human prostatacancer, og anvendelser deraf

Info

Publication number
DK1200590T3
DK1200590T3 DK00953992T DK00953992T DK1200590T3 DK 1200590 T3 DK1200590 T3 DK 1200590T3 DK 00953992 T DK00953992 T DK 00953992T DK 00953992 T DK00953992 T DK 00953992T DK 1200590 T3 DK1200590 T3 DK 1200590T3
Authority
DK
Denmark
Prior art keywords
prostate cancer
human prostate
antigen expressed
type lectin
transmembrane antigen
Prior art date
Application number
DK00953992T
Other languages
Danish (da)
English (en)
Inventor
Daniel E H Afar
Rene S Hubert
Aya Jakobovits
Arthur B Raitano
Original Assignee
Agensys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agensys Inc filed Critical Agensys Inc
Application granted granted Critical
Publication of DK1200590T3 publication Critical patent/DK1200590T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK00953992T 1999-08-12 2000-08-11 C-type lectin-transmembran-antigen, der udtrykkes ved human prostatacancer, og anvendelser deraf DK1200590T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14893599P 1999-08-12 1999-08-12
PCT/US2000/022065 WO2001012811A1 (fr) 1999-08-12 2000-08-11 Antigene transmembranaire lectine du type c exprime dans le cancer humain de la prostate et ses utilisations

Publications (1)

Publication Number Publication Date
DK1200590T3 true DK1200590T3 (da) 2009-03-16

Family

ID=22528098

Family Applications (2)

Application Number Title Priority Date Filing Date
DK00953992T DK1200590T3 (da) 1999-08-12 2000-08-11 C-type lectin-transmembran-antigen, der udtrykkes ved human prostatacancer, og anvendelser deraf
DK08163095.6T DK1992695T3 (da) 1999-08-12 2000-08-11 Lectin-transmembran-antigen af type C udtrykt i human prostatacancer og avendelser deraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK08163095.6T DK1992695T3 (da) 1999-08-12 2000-08-11 Lectin-transmembran-antigen af type C udtrykt i human prostatacancer og avendelser deraf

Country Status (13)

Country Link
US (6) US6602501B1 (fr)
EP (2) EP1200590B1 (fr)
JP (3) JP4373637B2 (fr)
AT (2) ATE420175T1 (fr)
AU (5) AU774436B2 (fr)
CA (1) CA2380550C (fr)
CY (2) CY1110256T1 (fr)
DE (2) DE60041333D1 (fr)
DK (2) DK1200590T3 (fr)
ES (2) ES2317846T3 (fr)
IL (3) IL147902A0 (fr)
PT (2) PT1200590E (fr)
WO (1) WO2001012811A1 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
PT1609863E (pt) * 1999-03-23 2009-01-02 Genentech Inc Polipéptidos segregados e transmembranares e ácidos nucleicos que os codificam
AU2005205754B2 (en) * 1999-03-23 2007-09-20 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1046651A1 (fr) * 1999-04-19 2000-10-25 Koninklijke Universiteit Nijmegen Composition et méthode pour moduler l'interaction des cellules dendritiques et les cellules T
EP1200590B1 (fr) 1999-08-12 2009-01-07 Agensys, Inc. Antigene transmembranaire lectine du type c exprime dans le cancer humain de la prostate et ses utilisations
US7842458B2 (en) 1999-08-12 2010-11-30 Agensys, Inc. Nucleic acids and corresponding proteins entitled 58P1D12 useful in treatment and detection of cancer
US7449548B2 (en) 2001-12-07 2008-11-11 Agensys, Inc. Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
TW200413725A (en) * 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
CA2576500A1 (fr) * 2004-08-16 2006-03-02 Agensys, Inc. Acides nucleiques et proteines correspondantes appeles 58p1d12 utiles dans le traitement et la detection du cancer
US9492400B2 (en) * 2004-11-04 2016-11-15 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
GB0426822D0 (en) * 2004-12-07 2005-01-12 Precisense As Sensor for detection of glucose
GB0426823D0 (en) 2004-12-07 2005-01-12 Precisense As Sensor for detection of glucose
WO2007070682A2 (fr) * 2005-12-15 2007-06-21 Massachusetts Institute Of Technology Systeme de criblage de particules
JP2009534309A (ja) * 2006-03-31 2009-09-24 マサチューセッツ インスティテュート オブ テクノロジー 治療剤の標的化送達のためのシステム
JP5630998B2 (ja) 2006-05-15 2014-11-26 マサチューセッツ インスティテュート オブ テクノロジー 機能的粒子のためのポリマー
US20110052697A1 (en) * 2006-05-17 2011-03-03 Gwangju Institute Of Science & Technology Aptamer-Directed Drug Delivery
WO2007150030A2 (fr) 2006-06-23 2007-12-27 Massachusetts Institute Of Technology Synthèse microfluidique de nanoparticules organiques
US20100303723A1 (en) * 2006-11-20 2010-12-02 Massachusetts Institute Of Technology Drug delivery systems using fc fragments
WO2008098165A2 (fr) * 2007-02-09 2008-08-14 Massachusetts Institute Of Technology Bioréacteur oscillant pour la culture de cellules
WO2008124632A1 (fr) 2007-04-04 2008-10-16 Massachusetts Institute Of Technology Nanoparticules assistées par des composés amphiphiles pour délivrance ciblée
WO2008124634A1 (fr) 2007-04-04 2008-10-16 Massachusetts Institute Of Technology Micelles inverses encapsulées par un polymère
AU2008314647B2 (en) 2007-10-12 2013-03-21 Massachusetts Institute Of Technology Vaccine nanotechnology
WO2010022279A1 (fr) * 2008-08-20 2010-02-25 Agensys, Inc. Anticorps et molécules associées qui se lient à des protéines 58p1d12
US8343498B2 (en) * 2008-10-12 2013-01-01 Massachusetts Institute Of Technology Adjuvant incorporation in immunonanotherapeutics
US8277812B2 (en) 2008-10-12 2012-10-02 Massachusetts Institute Of Technology Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
US8591905B2 (en) 2008-10-12 2013-11-26 The Brigham And Women's Hospital, Inc. Nicotine immunonanotherapeutics
US8343497B2 (en) 2008-10-12 2013-01-01 The Brigham And Women's Hospital, Inc. Targeting of antigen presenting cells with immunonanotherapeutics
CN105238781B (zh) * 2015-11-06 2018-02-16 福建省农业科学院果树研究所 基于转录组序列开发的李ssr标记引物对及其应用
US10543288B2 (en) 2017-04-28 2020-01-28 Medtronic Minimed, Inc. Modified-dextrans for use in optical glucose assays
US10792378B2 (en) 2017-04-28 2020-10-06 Medtronics Minimed, Inc. Using a blue-shifted reference dye in an optical glucose assay

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4870009A (en) 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
DE3675588D1 (de) 1985-06-19 1990-12-20 Ajinomoto Kk Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist.
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
GB8724885D0 (en) 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
US4975287A (en) 1989-09-01 1990-12-04 Wm. Wrigley Jr. Company Gum composition containing protein macrocolloids
US5723286A (en) 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
DK1013666T3 (da) 1990-06-27 2006-08-14 Univ Princeton Proteinkompleks p53/p90
US5733731A (en) 1991-10-16 1998-03-31 Affymax Technologies N.V. Peptide library and screening method
US5879898A (en) * 1992-11-20 1999-03-09 Isis Innovation Limited Antibodies specific for peptide corresponding to CD44 exon 6, and use of these antibodies for diagnosis of tumors
CH686982A5 (fr) 1993-12-16 1996-08-15 Maurice Stroun Méthode pour le diagnostic de cancers.
US6004746A (en) 1994-07-20 1999-12-21 The General Hospital Corporation Interaction trap systems for detecting protein interactions
US5919652A (en) 1994-11-09 1999-07-06 The Regents Of The University Of California Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof
NZ306767A (en) 1995-04-11 2000-03-27 Univ Johns Hopkins Method of identifying molecular interactions employing counterselection and at least two hybrid molecules or two hybrid systems
US5681923A (en) * 1995-10-06 1997-10-28 Platt; David Tumor derived carbohydrate binding protein
US6476192B1 (en) * 1996-04-15 2002-11-05 Nicola C. Lally Recombinant antigens useful for the serodiagnosis of neosporosis
US6117977A (en) * 1996-04-24 2000-09-12 Genentech, Inc. Type C lectins
US5928868A (en) 1996-04-26 1999-07-27 Massachusetts Institute Of Technology Three hybrid screening assay
US5925523A (en) 1996-08-23 1999-07-20 President & Fellows Of Harvard College Intraction trap assay, reagents and uses thereof
ATE371721T1 (de) 1996-10-15 2007-09-15 Univ California Tiermodelle für die menschliche prostatakrebsfortschreitung
US5846722A (en) 1996-10-16 1998-12-08 Terrapin Technologies, Inc. System to detect small molecule/peptide interaction
CA2273194C (fr) 1996-12-03 2011-02-01 Abgenix, Inc. Mammiferes transgeniques possedant des loci de genes d'immunoglobuline dorigine humaine, dotes de regions vh et vk, et anticorps produits a partir de tels mammiferes
US20030004311A1 (en) 1997-06-18 2003-01-02 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20020137890A1 (en) 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7435793B2 (en) 1998-05-15 2008-10-14 Genentech, Inc. Peptides that induce chondrocyte redifferentiation
US20030022239A1 (en) 1997-06-18 2003-01-30 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7285625B2 (en) * 1997-06-18 2007-10-23 Genentech, Inc. PRO536 polypeptides
US20030166104A1 (en) 1997-09-18 2003-09-04 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030166109A1 (en) 1997-09-18 2003-09-04 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7160985B2 (en) 1997-10-29 2007-01-09 Genentech, Inc. Pro180 polypeptide
US7125959B2 (en) 1998-05-15 2006-10-24 Genentech, Inc. PRO4405 polypeptides
PT1082341E (pt) 1998-06-01 2011-02-15 Agensys Inc Antigénio de tumor útil em diagnóstico e terapêutica de cancro da próstata e do cólon
EP1100869A4 (fr) 1998-07-30 2005-04-27 Human Genome Sciences Inc 98 proteines humaines secretees
US20030050465A1 (en) 1998-08-10 2003-03-13 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2000039296A1 (fr) * 1998-12-23 2000-07-06 Immunex Corporation Polypeptides et adn s3939 de lectine
US20030009013A1 (en) 1998-12-30 2003-01-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
PT1609863E (pt) 1999-03-23 2009-01-02 Genentech Inc Polipéptidos segregados e transmembranares e ácidos nucleicos que os codificam
EP1074617A3 (fr) 1999-07-29 2004-04-21 Research Association for Biotechnology Amorces pour la synthèse de cADN de pleine longueur et leur utilisation
EP1200590B1 (fr) 1999-08-12 2009-01-07 Agensys, Inc. Antigene transmembranaire lectine du type c exprime dans le cancer humain de la prostate et ses utilisations
US7555263B1 (en) * 1999-10-21 2009-06-30 Broadcom Corporation Adaptive radio transceiver
US7300758B2 (en) 1999-12-09 2007-11-27 Genetech, Inc. Nucleic acid underexpressed in esophageal tumor
JP3467264B2 (ja) * 2000-03-21 2003-11-17 三菱レイヨン株式会社 微生物の培養法
US7250495B2 (en) 2001-06-20 2007-07-31 Genentech, Inc. PRO20044 polypeptides
JP3921367B2 (ja) * 2001-09-26 2007-05-30 日本電気株式会社 データ処理装置および方法、コンピュータプログラム、情報記憶媒体、並列演算装置、データ処理システム
US7202335B2 (en) 2001-12-06 2007-04-10 Genentech, Inc. PRO300 polypeptides
JP2004187620A (ja) 2002-12-13 2004-07-08 Sumitomo Pharmaceut Co Ltd 腎疾患の疾患マーカーおよびその利用
US20090068098A1 (en) 2007-08-20 2009-03-12 Kanner Steven B Antibodies and related molecules that bind to 58p1d12 proteins

Also Published As

Publication number Publication date
WO2001012811A1 (fr) 2001-02-22
PT1992695E (pt) 2011-01-12
AU2009200299B2 (en) 2011-12-22
DE60045201D1 (de) 2010-12-16
EP1992695B1 (fr) 2010-11-03
DE60041333D1 (de) 2009-02-26
EP1992695A2 (fr) 2008-11-19
IL147902A0 (en) 2002-08-14
JP2009235109A (ja) 2009-10-15
CA2380550A1 (fr) 2001-02-22
US7087718B2 (en) 2006-08-08
US7148337B2 (en) 2006-12-12
AU2004203513B2 (en) 2006-05-11
AU2009200299A1 (en) 2009-02-19
CA2380550C (fr) 2011-02-01
AU2009200576A1 (en) 2009-03-05
AU2006203476A1 (en) 2006-08-31
ATE486938T1 (de) 2010-11-15
CY1111147T1 (el) 2015-06-11
JP2006204306A (ja) 2006-08-10
CY1110256T1 (el) 2015-01-14
PT1200590E (pt) 2009-03-24
US20040038271A1 (en) 2004-02-26
AU6635100A (en) 2001-03-13
US20040265898A1 (en) 2004-12-30
US8022174B2 (en) 2011-09-20
EP1200590B1 (fr) 2009-01-07
DK1992695T3 (da) 2011-02-14
US7153940B2 (en) 2006-12-26
JP2003507042A (ja) 2003-02-25
AU2004203513A1 (en) 2004-08-26
ATE420175T1 (de) 2009-01-15
US20100028374A1 (en) 2010-02-04
AU774436B2 (en) 2004-06-24
IL147902A (en) 2011-04-28
US20070092918A1 (en) 2007-04-26
US20050019872A1 (en) 2005-01-27
EP1992695A3 (fr) 2009-01-07
EP1200590A1 (fr) 2002-05-02
ES2317846T3 (es) 2009-05-01
ES2355428T3 (es) 2011-03-25
AU2009200576B2 (en) 2011-12-22
JP4373637B2 (ja) 2009-11-25
US6602501B1 (en) 2003-08-05
US7598045B2 (en) 2009-10-06
IL197988A (en) 2011-12-29

Similar Documents

Publication Publication Date Title
DK1200590T3 (da) C-type lectin-transmembran-antigen, der udtrykkes ved human prostatacancer, og anvendelser deraf
WO2002046477A3 (fr) Retrovirus endogenes regules positivement dans le cancer de la prostate
HK1145692A1 (zh) 人血管生成素- 的特異結合劑
AU9312198A (en) Genes amplified in tumours, antibodies against the proteins encoded thereby, andtheir use in diagnosis and treatment of cancer
DE69942031D1 (de) In prostatakrebs exprimiertes gen
WO2003070889A3 (fr) Genes specifiques de la prostate et leur utilisation dans la conception ou la therapie
IL207012A (en) 28sgp medicinal product and 28sgp accent cancer treatment vaccine
WO2003013431A3 (fr) Compositions et techniques de therapie et de diagnostic du cancer du sein
MXPA02011563A (es) Composicionesy metodos para la terapia y diagnostico de cancer de seno.
DE60130541D1 (de) Gewebe-spezifische protein 103p2d6, hochexprimiert in verschiedene krebsarten
ATE501255T1 (de) 84p2a9: prostata- und hodenspezifisches protein, das sehr stark bei prostatakrebs vorkommt
WO2003080800A3 (fr) Prevention et traitement de maladies au moyen d'angiogenese et/ou d'antigenes tumoraux
AU2002228940A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2001059110A3 (fr) 34p3d7: proteine specifique aux tissus hautement exprimes dans le cancer de la prostate
WO2001059115A3 (fr) Le 83p5g4: proteine specifique de tissus fortement exprime dans le cancer de la prostate
WO2001098339A3 (fr) Compositions et procedes de traitement et de diagnostic du cancer du sein
WO2002085286A3 (fr) Procedes permettant d'utiliser la chimiokine d'organes lymphoides secondaires pour moduler des processus physiologiques chez des mammiferes
WO2003020294A8 (fr) Marquage d'aromatase
AU2002366631A1 (en) Human prostate cancer candidate protein 1
AU2002243918A1 (en) Methods for the treatment and diagnosis of prostate cancer based on p75ntr tumor
TW200635953A (en) Specific binding agents of human angiopoietin-2